Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04107129 · ClinicalTrials.gov registry record
Predicting Endometrial Receptivity for Optimal Reproductive Management
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 76
- Enrollment target
NCT04107129: Completed study, sponsored by Stanford University.
NCT04107129 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 76 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04107129 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
The purpose of this study is to understand why some women are infertile (unable to conceive a child). The investigators hope to learn if an endometrial biopsy after egg retrieval is feasible for detecting biomarkers for endometriosis and predicting implantation and pregnancy rate after embryo transfer. This study design will provide for the first time, an opportunity to compare endometrial biopsy material from hyperstimulated (gonadotropin treated) subjects after egg retrieval. If successful, it would provide a new protocol for women with unexplained infertility or those with known endometriosis to avoid poor IVF outcomes.
Interventions
- DIAGNOSTIC_TEST Blood sample
- PROCEDURE Endometrial Biopsy
- OTHER Euploid embryo transfer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2024-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04107129
The ClinicalTrials.gov registry entry for NCT04107129 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blood sample is the first listed.
NCT04107129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04107129 about?
NCT04107129 is a clinical study titled "Predicting Endometrial Receptivity for Optimal Reproductive Management". The purpose of this study is to understand why some women are infertile (unable to conceive a child). The investigators hope to learn if an endometrial biopsy after egg retrieval is feasible for detecting biomarkers for endometriosis and predicting implantation and pregnancy rate after embryo transf...
What is the current status of trial NCT04107129?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2020-07-01. Estimated completion is 2024-07-30.
What interventions are being tested in trial NCT04107129?
The interventions under investigation include: Blood sample (DIAGNOSTIC_TEST), Endometrial Biopsy (PROCEDURE), Euploid embryo transfer (OTHER).
Who is sponsoring clinical trial NCT04107129?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.